As shown in Figure 1A, IL-17 was significantly higher in CAPS patients (median 5,1 pg/ml range:0–14.4) when compared to healthy controls [0.4 pg/ml, 0–6.5 pg/ml) (p = 0.04). This evidence concerns the gene IL17A and cryopyrin-associated periodic syndrome.